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An Abstract of Results of Laboratory
Examinations of Patients with Yusho and of
Animal Experiments
byMasanori Kuratsune
An extensive clinical study of Yusho and many
animal experiments were carried out by the Yusho
study group in Kyushu University in order to
* Department of Public Health, Faculty of Medicine,
Kyushu University, Fukuoka, Japan.
clarify the mechanism of toxic actions of
Kanechlor. Most of the findings have been pub-
lished in Japanese with brief English abstracts.
I hope this abstract will help in the understanding
of the important observations obtained by these
studies.
Table 1. Laboratory findings of patients with Yusho.
Item Laboratory findings Reference
Blood (I)
1. Red blood cells
2. Leucocytes
3. Blood platelets
4. Coagulation time
5. Prothrombin time
6. Blood sedimentation
rate
7. Hemoglobin
Blood (II) serum lipids
1. Total lipid
2. Triglycerides
Decreased in most severe cases.
Increased in most severe cases.
Normal
Normal
Normal
Normal except for a few cases
Decreased in most severe cases
Increased
725.0d169.5 (mg %) 9 cases of grade IV*
Increased
180.6+88.2 (mg %) 9 cases of grade IV*
69-617 (mg %) 24 cases
More than 300 (mg %) 9 out of 24 cases
189-64 (mg %) 32 adult patients
Fifteen percent of the patients showed unusually high levels (more than
300 mg %) of triglycerides
age No. TG>300 %
cases No. case
0-9 52 18 34.6
10-19 89 17 19.1
20-29 68 5 7.4
30-39 85 10 11.8
40-49 58 6 10.3
50-59 28 2 7.2
60- 16 2 12.5
396 60 15.1
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Item Laboratory findings Reference
3. Cholesterol
4. Phospholipids
5. Serum lipoprotein
6. Fatty acid composi-
tion of serum lipids
7. Effect of glucose
administration on
serum free fatty acids
8. Post-heparin plasma
lipoprotein lipase
activity (PHLA)
9. Lecithin-cholesterol
acyltransferase (LCA)
Blood(III) proteinandothers
1. Total serum protein
2. Serum albumin
3. Serum globulin
4. Non-protein nitrogen
compounds
Blood (IV) electrolytes
and metals
1. Na, K, Ca
Normal
181±43 (mg %O) 27 adult patients
Normal
8.1i1.8 (mg %) 27 adult patients
,3/a-liproprotein ratio increased.
Woman with Yusho, aged 24: 2.0
Woman with Yusho, aged 60: 4.4
Man with Yusho, aged 35: 3.5
Analysis of cholesterol esters, triglycerides, free fatty acids, and phospho-
lipids showed no abnormal components, except that increase of oleic acid
and decrease of palmitic acid were seen in serum-free fatty acids.
Levels of glucose and free fatty acids in blood were determined 30, 60, 90,
120, 150, and 180 minutes after oral administration of 50 g glucose.
Two types of variation of levels were noted.
Type A: Blood glucose increased and later decreased. Fatty acids
hardly changed.
Type B: Blood glucose increased and did not return to normal even after
180 minutes after glucose administration. Fatty acids decreased
markedly after administration.
Palmitic acid decreased by glucose administration more markedly in
patients than in normal persons.
PHLA values (FFA gEq/min/ml) 10 minutes after heparin injection in 10
normal women aged 18 to 20 in years were 0.2014±0.058. Four of 5
female patients showed PHLA 10 minute values lower than 0.143, namely
the mean-1 S.D. value for control, while 2 of 8 male patients had
similar low values.
Five patients with Yusho were examined. Mean value was 41.7% for
patients which was significantly lower than control (p=0.02)
Normal in most cases
6.87±0.73 (g %) 9 cases of grade IV*
7.3±0.6 (g %) 35 adult patients
7.3±0.5 (g %) 8 Yusho children
Normal
56.4±5.47 (%) 9 cases of grade IV*
59.4±4.2 (%) 33 adult patients
58.1±6.6 (%) 8 Yusho children
Increase in a2-globulin in severe cases.
No significant change in other fractions.
a2-globulin
12.7±2.74 (%) 9 cases of grade IV*
10.3±2.1 (%) 33 adult patients
13.1±3.0 (%) 8 Yusho children
Increase in a,-globulin
6.2±1.1 (%) 33 adult patients
6.0 1.0 (%) 8 Yusho children
Normal
Normal
Na and Ca were in normal range but K is slightly decreased.
4.0±0.4 (mEq/1) 53 adult patients
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4.240.5 (mEq/1) 17 Yusho children
Normal
Tended to decrease.
66.0±30.9 (,ug %) 6 cases of grade IV*
Decreased
90434 (pg %) 50 adult patients
83±26 (,ug %) 17 Yusho children
Increased in severe cases
183.9±61.0 (pg %) 9 cases of grade IV*
Normal
Blood (V) enzymes
1. Alkaline phosphatase,
serum
2. Lactate dehydroge-
nase (LDH), serum
3. Transaminases
GOT
GPT
Blood (VI) others
1. Bromsulfalein (BSP)
test
2. Icterus index
3. I131 resin sponge
uptake (Triosorb test)
Urine
1. Protein
2. Glucose
3. Urobilinogen
4. Urinary neutral
17-ketosteroids
Increased slightly in severe cases.
10.3±3.5 (King-Armstrong units) 65 adult patients
17.4±4.9 (King-Armstrong units) 11 Yusho children
14.9±9.26 (King-Armstrong units) 9 cases of grade IV*
Normal in most cases.
278±65 (Karmen units) 24 adult patients
284t24 (Karmen units) 5 Yusho children
Normal
2419 (Karman units) 70 adult patients
36t23 (Karman units) 12 Yusho children
23.0±7.7 9 cases of grade IV*
28.0±10.2 cases of grade IV*
24.7±8.8 cases of grade III
20.0±7.3 cases of grade II
Normal in most cases
22.6±11.9 7 cases of grade IV*
23±16 (Karman units) 48 adult patients
21±11 (Karman units) 10 Yusho children
Mean 30.1 cases of grade IV*
Mean 24.1 cases of grade III
Mean 16.0 cases of grade II
Delayed in several adult cases.
5.9±5.19 (%) 8 cases of grade IV*
Normal
3.3±0.66 8 cases of grade IV*
Normal
Negative
Negative
Negative in most cases
Elevation of ratio of etiocholanolone/androsterone was noted, indicating
adrenocortical hyperfunction but urinary excretion of total 17-ketosteroids
was in normal range.
Etiochol./androst.
2 Normal women aged 28: 0.6, 1.0
2 Normal men aged 20 and 28: 0.4, 0.8
2 Yusho women aged 35: 1.7, 2.0
2 Yusho men aged 37 and 39: 0.9, 2.6
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Total 17-ketosteroids
23 adult Yusho women: 5.7±1.8 (mg/day)
13 adult Yusho men: 7.3-±2.8 (mg/day)
Urinary total 17-ketosteroids (17-KS) and 17-hydroxycorticosteroid
(17-OHCS) were determined in 50 male and 45 female patients. Positive
correlation was found between 17-KS and 17-OHCS. 42% of patients
exceeded normal range in both steroids in males and females.
Analysis of major components of urinary 17-KS was made in 9 male (19 to
57 years in age) and 7 female (16 to 51 years in age) patients.
For androsterone, etiocholanolone, and dehydroepiandrosterone, female
patients seemed to be lower than control, while male patients seemed to
be higher.
Normal (mg/day) Patients (mg/day)
5. Amino acids
Fatty acid analysis of acne
and skinfat
1. Cheese-like material
collected from acne
eruptions and fat in
the sweat of patients
M Pregnanediol 0.70±0.17 0.8440.46
Androsterone 2.95±1.02 3.2841.19
Etiocholanolone 1.834±0.55 2.64±i0.84
Dehydroepiandrosterone 1.55±L:0.75 1.96± 1.18
Total 6.4±1.8 7.9±3.2
Determined by
Zimmermann reaction 10.6+2.3 11.6±3.2
F Pregnanediol 0.95±0.55 1.34±+0.91
Androsterone 2.02±40.97 1.32±-0.60
Etiocholanolone 1.35±0.48 1.03+0.40
Dehydroepiandrosterone 1.01±0.40 0.93±+0.48
Total 4.441.7 3.8±1.0
Determined by
Zimmermann reaction 6.1±2.4 7.2±-1.9
Two patients were examined. A remarkable increase in excretion was noted 8
for taurine (5,641; 8,103 ,uM/day), 0-aminoisobutyric acid (247; 1,042
MM/day), glycine (1,865; 2,997 MM/day), and histidine (743; 1,170
MuM/day). Increase was also noted for threonine, serine, and Tyrosine.
cheese-like Fat in sweat 1
material
% Face Body
myristic 2.7 11.7 9.1
palmitic 21.5 41.2 41.0
palmitoleic 10.4 23.5 22.7
stearic 16.3 11.8 9.1
oleic 30.4 11.8 18.1
linoleic 18.3
linolenic 0.4
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2. Yusho acne and
non-Yusho acne
Yusho acne contained more stearic and oleic acids than did non-Yusho
acne. Linoleic acid was present only in the former. The former contained
10 times more cholesterol than the latter.
Cheese like materials
from ordinary from acnes of members of a
acnes of many Yusho family
persons %
1 2
myristic 11.6 3.0 8.3
palmitic 41.2 22.1 23.4
palmitoleic 17.0 10.7 6.1
stearic 13.7 16.6 31.2
oleic 16.5 31.5 23.5
linoleic none 16.1 7.5
Biopsy
1. Liver
2. Skin
Neurologicalfindings
Otorhinolaryngological
findings
Ocular signs
Reduction of rough endoplasmic reticulum and hypertrophy of smooth
endoplasmic reticulum. Mitochondria showed morphological hetero-
geneity. Many filamentous inclusions were present in the matrix. Giant
mitochondria were frequently encountered.
Twenty-four biopsy specimens from 18 patients were examined. Marked
hyperkeratosis and cystic dilation of hair follicles; marked increase of
melanine in basal cells of epidermis.
Slowing of sensory nerve conduction velocities of radial and sural nerves was
noted in 9 of 23 patients examined. Motor nerve conduction velocities of
ulnar and tibial nerves were shown to be unaffected except for 2 patients
in whom they decreased.
No audiometric abnormality and no disturbed vestibular function.
Hypersecretion of meibomian gland; abnormal pigmentation of conjunctiva;
no particular lesion in intraocular tissues. Increase of melanine granules
was noted electronmicroscopically in cytoplasm of epithelial cells, especially
in basal cells of conjunctiva. Innumerable electron dense particles, 300-
400 A in diameter, were in the cytoplasm of basal cells.
5, 22
9
6
7
* Grade IV means clinically most severe cases.
Table 2. Findings of animal experiments
Experimental Results Reference
1. 2 ml of olive oil containing Increase of serum triglycerides and slight increase of total 4
1% Kanechlor 400 orally cholesterol (Uzawa et al.)
given to rabbits daily for 10
days
2. Oral administration of Kane- Enlargement of liver; slight fatty metamorphosis of liver; 10
chlor 400 to female mice, swelling of sebaceous gland. Increase of smooth endoplasmic (Nishizumi et al.)
cynomolgus monkeys, and reticulum and decrease of rough endoplasmic reticulum in
April 1972
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squirrel-monkeys for a month liver.
or longer.
3. Oral administration of 0.1 g of Loss of body weight, hepatomegaly, and marked increase in
Kanechlor per Kg per day to serum lipid components were noted. Serum triglycerides
rats for 4 weeks. reached a level as high as 10 times the control level. Serum
cholinesterase activity was not affected.
4. Oral administration of the rice Hyperkeratosis, cystic dilatation of hair follicle and sweat-
oil used by a Yusho patient to gland, marked hepatomegaly, fatty degeneration of liver.
hairless mice.
5. Distribution and elimination Each component of Kanechlor 400 was equally absorbed from
of components of Kanechlor gastro-intestinal tract. Concentration of Kanechlor 400 in
400 orally administered in a skin one day after administration was twice that in liver and
single dose of 2.0 mg/body to kidney. Kanechlor 400 was retained in skin more than in
female mice. other tissues. Tetrachlorobiphenyls were almost completely
eliminated from tissues in three to four weeks, but penta- and
hexa-chlcrobiphenyls were retained 9 to 10 weeks after
administration.
6. Distribution and excretion of Radioactivity in skin, adipose tissue, liver, adrenal gland and
3H-Kanechlor orally adminis- gastrointestinal tract was higher than in plasma 3 days after
tered in a single dose of 500 administration. Radioactivity was noted in some tissues after
,pc or 25 mg/body to Wistar 8 weeks. Urinary excretion of Kanechlor was limited, while
King male rats weighing 70% of the dose given was in feces. A small portion of radio-
about 150 g. activity excreted during the first day was in the phenolic
fraction. More phenolic metabolites and less unchanged com-
ponents were excreted in the feces on the second and third
day.
7. Effect of oral administration Kanechlor 400, 500, 600: Hepatomegaly. Microsomal protein
of Kanechlor 400, 500, 600 per gram of liver increased in proportion to chlorine content
and their components, 0.2 ml of Kanechlor. Amount of cytochrome P-450 and specific ac-
of a solution of 6.8 mg/0.2 tivities of O-dealkylase (p-nitrophenetol), N-demethylase
ml/100 g of body weight, (p-chloro-N-methylaniline), and aniline hydroxylase, in-
daily for 3 days, on liver mi- creased, particularly with Kanechlor 500.
crosomes of male rats. 4,4'-dichlorobiphenyl: Slight increases seen.
3,4,2',4'-tetrachlorobiphenyl'l: Increases noted, but less than
3,4,3',4'-tetrachlorobiphenylJ with Kanechlor 400.
3,4,3',4'-tetrachlorobiphenyl was a more potent inducer than
the others.
2,4,5,3',4'-pentachlorobiphenyl: Most marked increases were
noted in cyt. P450 and specific activities of 3 enzymes.
3,4,5,3',4',5'-hexachlorobiphenyl: The increase was larger
than that induced with the tetra chlorobiphenyls but less
than that with the pentachlorobiphenyl.
Phenobarbital: Resembling Kanechlor 400 in enzyme induction
capability.
The above microsomal enzyme activities and the microsomal
components started to increase 12 hours after administration
of 3,4,3',4'-tetrachlobiphenyl, reaching the maximum after
about 1 week. Thereafter, activity levels tended to decrease
but did not return to normal even after 6 weeks. Microsomes,
particularly their membranes, contained the largest amount
of H3-Kanechlor-400 administered orally, as compared with
mitochondria or lysosomes.
11
(Tanaka et al.)
12
(Inagami et al.)
13
(Yoshimura et al.)
14
(Yoshimura et al.)
15
(Fujita et al.)
8. Oral administration of Kane- Hexobarbital sleeping time was markedly shortened by pre- 16
chlor 400 or 500 to female rats treatment with Kanechlor 400 or 500 in rats. Minimum effec- (Komatsu-et al.)
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(Wistar King), about 100 g in
weight, in order to see effects
of the administration on
hexobarbital sleeping time
9. Oral administration of daily
dose of 0.5, 2.5, 5, 50 mg of
Kanechlor to rats for 13 to 21
days.
10. Oral administration of Frac-
tion A and B of Kanechlor
400 to rats, each daily dose 1
mg on every fourth day for 40
days, 10 mg total.
Fr. A: Boiling point 123-
124°C/0.01 mmHg, 3.12
chlorine atoms per biphenyl
average.
Fr. B: Boiling point 140-
142°C/0.01 mmHg, 3.84
chlorine atoms per biphenyl
average.
11. Lipid in liver.
Oral administration of daily
dose of 8 ml of olive oil con-
taining 1% Kanechlor for 3
and 11 days to 2 female
rabbits.
tive dose was daily 5 mg and 2 mg/Kg for 3 days for Kane-
chlor 400 and 500, respectively. When 40 mg/Kg of
Kanechlor 400 or 500 was given daily for 3 days, the effect
lasted for 3 weeks by the former and for 6 weeks by the
latter.
Ethionine inhibited the shortening of hexobarbital sleeping time
by Kanechlor.
Anabolic steroids, chloroquine, glutathione, a-mercaptopro-
pionylglyeine, essential phospholipids, diphenyl, and sulfa-
diazine did not modify the sleeping time reduction by
Kanechlor.
Growth was inhibited by the treatments. No weight increase at
daily dose of 5 mg, and a weight decrease at 50 mg. Plasma
triglycerides did not increase at daily dose up to 5 mg, and
slightly exceeded the control at dose of 50 mg, while plasma
cholesterol and phospholipid increased definitely by increas-
ing amount of Kanechlor.
17
(Nagai et al.)
Daily dose Triglyceride Cholesterol Phospholipid
Kanechlor JAM % mg % mg %
(mg)
Control 109±426 83-12 4.7±0.8
0.5 98+19 118+26 5.8+1.7
2.5 89+21 102+11 7.2+1.2
5.0 89+18 125+28 7.1+1.3
50.0 130+37 178+18 13.4+2.2
The administrations hardly affected concentration of triglyc-
eride, cholesterol, phospholipid in liver except for daily ad-
ministration of 50 mg Kanechlor, which caused slight increase
of triglyceride and cholesterol. They slightly increased tri-
glyceride in skin but hardly affected cholesterol and phos-
pholipid. A'definite reduction of triglyceride in perirenal
adipose tissue was noted.
Animals grew in weight with Fr. A but lost weight with Fr. B, 17
which caused marked atrophy of abdominal adipose tissue. (Nagai et al.)
Lipid content of adipose tissue around kidney decreased when
Fr. B was given but did not when Fr. A given. Plasma tri-
glyceride decreased with Fr. B but did not with Fr. A.
Animal Triglyceride Cholesterol Phospholipid
JAM % mg % mg %
Control 130±18 66±45 5.7±0.4
Fr. A 128±10 66±7 5.1±0.4
Fr. B 83±21 57±5 5.2±0.3
Total lipid and glycerides of liver increased, but concentration 18
of serum glycerides was normal after administration for 3 (Ito et al.)
consecutive days, but increased abnormally after administra-
tion for 11 consecutive days.
Lipid
Control Poisoned Poisoned
(n=1) for 3 days for 11 days
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(n=l) (n=l)
Total lipid
%/dry wt. 17 29 30
Glycerides 7.1% 24.3% 25.3%
Cholesterol 6.3 6.1 10.8
CGP Lecithin 22.5 9.7
Lysolecithin 7.4 30.0 7.6
Sphingomyelin 2.9 4.8
EGP 16.9 14.4
SGP 9.0 4.5
PI 6.8 39.6 5.1
Glycolipid 5.2 6.7
Others 15.9 11.1
Serum glycerides 52 65 1,690
(mg %)
12. Oral administration of daily Marked or moderately impaired motor function, decreased 21
dose 0.5 or 0.3 mg/Kg of motor conduction velocity, early stage of segmental demye-
Kanechlor 400 each to 40 lination and loss of large nerve fibers were noted.
adult Wistar rats.
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